High Mobility Group Box2 Promoter-controlled Suicide Gene Expression Enables Targeted Glioblastoma Treatment

Pulkkanen, 2005, Gene therapy for malignant glioma: current clinical status, Mol Ther, 12, 585, 10.1016/j.ymthe.2005.07.357 Harrington, 2000, Transcriptional control: an essential component of cancer gene therapy strategies?, Adv Drug Deliv Rev, 44, 167, 10.1016/S0169-409X(00)00093-4 Robson, 2003, Transcriptional targeting in cancer gene therapy, J Biomed Biotechnol, 2003, 110, 10.1155/S1110724303209074 King, 2005, Gene therapy and targeted toxins for glioma, Curr Gene Ther, 5, 535, 10.2174/156652305774964631 Sadeghi, 2005, Transcriptionally targeted adenovirus vectors, Curr Gene Ther, 5, 411, 10.2174/1566523054546189 Chen, 1998, Differential inducibilities of GFAP expression, cytostasis and apoptosis in primary cultures of human astrocytic tumours, Apoptosis, 3, 171, 10.1023/A:1009698822305 McKie, 1998, Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector—potential glioblastoma targeting, Gene Ther, 5, 440, 10.1038/sj.gt.3300621 Vandier, 1998, Selective killing of glioma cell lines using an astrocyte-specific expression of the herpes simplex virus-thymidine kinase gene, Cancer Res, 58, 4577 Zamorano, 2004, Glial-specific retrovirally mediated gas1 gene expression induces glioma cell apoptosis and inhibits tumor growth in vivo, Neurobiol Dis, 15, 483, 10.1016/j.nbd.2003.11.022 Wang, 2006, Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy, Cancer Res, 66, 5798, 10.1158/0008-5472.CAN-05-4514 Horst, 2007, Targeting malignant gliomas with a glial fibrillary acidic protein (GFAP)-selective oncolytic adenovirus, J Gene Med, 9, 1071, 10.1002/jgm.1110 Bush, 1998, Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice, Cell, 93, 189, 10.1016/S0092-8674(00)81571-8 Delaney, 1996, Conditional ablation of cerebellar astrocytes in postnatal transgenic mice, J Neurosci, 16, 6908, 10.1523/JNEUROSCI.16-21-06908.1996 Bush, 1999, Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice, Neuron, 23, 297, 10.1016/S0896-6273(00)80781-3 Faulkner, 2004, Reactive astrocytes protect tissue and preserve function after spinal cord injury, J Neurosci, 24, 2143, 10.1523/JNEUROSCI.3547-03.2004 Rhodes, 2004, Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression, Proc Natl Acad Sci USA, 101, 9309, 10.1073/pnas.0401994101 Ronfani, 2001, Reduced fertility and spermatogenesis defects in mice lacking chromosomal protein Hmgb2, Development, 128, 1265, 10.1242/dev.128.8.1265 Barrett, 2005, NCBI GEO: mining millions of expression profiles—database and tools, Nucleic Acids Res, 33, D562, 10.1093/nar/gki022 Fukuda, 2006, Survivin, a cancer target with an emerging role in normal adult tissues, Mol Cancer Ther, 5, 1087, 10.1158/1535-7163.MCT-05-0375 Alavi, 2001, Gene therapy for high grade gliomas, Expert Opin Biol Ther, 1, 239, 10.1517/14712598.1.2.239 Sarkis, 2000, Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector, Proc Natl Acad Sci USA, 97, 14638, 10.1073/pnas.260472897 Lehtolainen, 2002, Baculoviruses exhibit restricted cell type specificity in rat brain: a comparison of baculovirus- and adenovirus-mediated intracerebral gene transfer in vivo, Gene Ther, 9, 1693, 10.1038/sj.gt.3301854 Li, 2004, Axonal transport of recombinant baculovirus vectors, Mol Ther, 10, 1121, 10.1016/j.ymthe.2004.08.018 Wang, 2006, Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter, Gene Ther, 13, 1447, 10.1038/sj.gt.3302771 Thomas, 2001, HMG1 and 2: architectural DNA-binding proteins, Biochem Soc Trans, 29, 395, 10.1042/bst0290395 Koon, 2004, Molecular targets for tumour progression in gastrointestinal stromal tumours, Gut, 53, 235, 10.1136/gut.2003.021238 Varma, 2005, Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10, Oncol Rep, 14, 925 Xing, 2004, Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis, J Exp Med, 199, 69, 10.1084/jem.20031588 Xie, 2006, Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma, Br J Cancer, 94, 108, 10.1038/sj.bjc.6602904 Van Houdt, 2006, The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma, J Neurosurg, 104, 583, 10.3171/jns.2006.104.4.583 Ulasov, 2007, Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma, Hum Gene Ther, 18, 589, 10.1089/hum.2007.002 Zhu, 2005, Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo, Int J Oncol, 27, 237 Sasaki, 2002, Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system, Acta Neuropathol, 104, 105, 10.1007/s00401-002-0532-x Pennartz, 2004, Purification of neuronal precursors from the adult mouse brain: comprehensive gene expression analysis provides new insights into the control of cell migration, differentiation, and homeostasis, Mol Cell Neurosci, 25, 692, 10.1016/j.mcn.2003.12.011 Jiang, 2005, Essential role for survivin in early brain development, J Neurosci, 25, 6962, 10.1523/JNEUROSCI.1446-05.2005 Ulasov, 2007, Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy, Cancer Biol Ther, 6, 679, 10.4161/cbt.6.5.3957 Herraiz, 2003, Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion, Hum Gene Ther, 14, 463, 10.1089/104303403321467225 van der Eb, 2003, Ganciclovir nucleotides accumulate in mitochondria of rat liver cells expressing the herpes simplex virus thymidine kinase gene, J Gene Med, 5, 1018, 10.1002/jgm.450 Brand, 1997, Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors, Cancer Gene Ther, 4, 9 van der Eb, 1998, Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration, Gene Ther, 5, 451, 10.1038/sj.gt.3300637 Thust, 2000, Cytogenetic genotoxicity of anti-herpes purine nucleoside analogues in CHO cells expressing the thymidine kinase gene of herpes simplex virus type 1: comparison of ganciclovir, penciclovir and aciclovir, Mutagenesis, 15, 177, 10.1093/mutage/15.2.177 Zhang, 2005, Development of an HSV-tk transgenic mouse model for study of liver damage, FEBS J, 272, 2207, 10.1111/j.1742-4658.2005.04644.x Wallace, 1996, Ganciclovir-induced ablation non-proliferating thyrocytes expressing herpesvirus thymidine kinase occurs by p53-independent apoptosis, Oncogene, 13, 55 Muller, 2004, Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function, J Intern Med, 255, 332, 10.1111/j.1365-2796.2003.01296.x Zeng, 2007, Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells, Stem Cells, 25, 1055, 10.1634/stemcells.2006-0616 Reubinoff, 2001, Neural progenitors from human embryonic stem cells, Nat Biotechnol, 19, 1134, 10.1038/nbt1201-1134 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262